Renvilda OD 100 Tablet is primarily used to manage type 2 diabetes mellitus in adults. This medicine belongs to the class of oral antidiabetic agents known as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Renvilda OD 100 Tablet is prescribed for:
• Managing type 2 diabetes mellitus in adults
• Swallow the tablet whole with a glass of water.
• Avoid chewing or crushing the tablet.
• You may take this medicine with or without food.
• Do not exceed the recommended dose without consulting your doctor.
• Consult your doctor before discontinuing the medicine.
Renvilda OD 100 Tablet is taken orally.
The common side effects of Renvilda OD 100 Tablet include:
• Headache
• Dizziness
• Nausea
• Diarrhoea
• Abdominal pain
Renvilda OD 100 Tablet contains vildagliptin (100 mg), which functions as follows:
• DPP-4 Inhibition: Vildagliptin blocks dipeptidyl peptidase-4 (DPP-4), an enzyme that degrades incretin hormones involved in glucose regulation.
• Increased Insulin Secretion: By inhibiting DPP-4, it elevates incretin levels, leading to enhanced insulin secretion from pancreatic beta cells.
• Reduced Glucagon Levels: It also decreases glucagon secretion from alpha cells, thereby reducing hepatic glucose production.
This tablet should be used only if potential benefit outweighs the potential risk to the fetus.
It is advisable to avoid this medicine while breastfeeding.
Increased risk of lactic acidosis.
Not recommended in patients with liver impairment.
Dosage adjustment is required in moderate and severe kidney impairment or end stage renal disease.
If dizziness or fatigue occurs, avoid such activities.
Do not take this medicine if you are allergic to vildagliptin or any other ingredients in the tablet.
Renvilda OD 100 Tablet is intended for adults only. It should not be given to children under 18 years of age.
Elderly patients may be more susceptible to side effects. Those above 70 years should take this medicine under medical supervision.
Drug-Drug Interactions
Renvilda OD 100 Tablet interacts with:
• Insulin Secretagogues: When combined with insulin secretagogues, such as sulfonylureas, the risk of hypoglycaemia may increase.
• ACE Inhibitors: There have been rare reports of angioedema when used with ACE inhibitors.
Drug-Disease Interactions
• Acute Pancreatitis: Contraindicated.
• Congestive Heart Failure: Contraindicated.
• Acute or chronic metabolic acidosis, including lactic acidosis or diabetic ketoacidosis, with or without coma: Contraindicated.
Daily Dose
• Take Renvilda OD 100 Tablet as advised by your doctor, based on your condition and response to the medicine.
Missed Dose
• If you forget to take your regular dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not double the dose.
Overdose
• Overdose symptoms may include headache, dizziness, or nausea. Seek medical attention immediately if an overdose is suspected.
• Store Renvilda OD 100 Tablet in a cool, dry place.
• Protect from light and moisture.
• Keep out of reach of children.
• Check the expiry date before use and do not use beyond this date.
• Limit sugar intake to help control blood glucose levels.
• Engage in regular physical activity, such as walking or yoga, to improve insulin sensitivity.
.avif)
%20(1).png)
.webp)